Kanawha Capital Management LLC Acquires 60 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kanawha Capital Management LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 519 shares of the medical equipment provider’s stock after buying an additional 60 shares during the period. Kanawha Capital Management LLC’s holdings in Intuitive Surgical were worth $255,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Ullmann Wealth Partners Group LLC increased its position in shares of Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC lifted its holdings in shares of Intuitive Surgical by 3.4% in the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after acquiring an additional 23 shares during the last quarter. Daymark Wealth Partners LLC boosted its stake in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock worth $3,452,000 after purchasing an additional 24 shares during the period. Indiana Trust & Investment Management CO grew its holdings in Intuitive Surgical by 5.3% during the 2nd quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock valued at $222,000 after purchasing an additional 25 shares during the last quarter. Finally, Hoxton Planning & Management LLC raised its position in Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock worth $238,000 after purchasing an additional 25 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Morgan Stanley raised their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Stock Up 0.2 %

Shares of ISRG opened at $507.42 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $269.49 and a twelve month high of $523.34. The company has a 50 day moving average of $490.97 and a two-hundred day moving average of $448.54. The company has a market cap of $180.73 billion, a price-to-earnings ratio of 81.58, a price-to-earnings-growth ratio of 4.95 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 68,246 shares of company stock worth $33,839,308. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.